Trial NCT03172936

View at ClinicalTrials.gov 
Org. Study IDs: CMIW815X2102J
Secondary IDs: 2017-000707-25

Last trial update was posted on 2022-05-03

MeSH Interventions

Spartalizumab

MeSH Conditions

Lymphoma

Other Conditions

Solid Tumors and Lymphomas

Stopping Reasons

Sponsor's decision

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID